primobolan depot

A complete description of the safety profile of intravenous ganciclovir are given below the corresponding adverse events identified with greater frequency, with oral ganciclovir in primobolan depot patients or after organ transplantation, regardless of their severity and causal relationship with the drug. Some adverse events with oral ganciclovir may be associated with this method of treatment. Blood System and Lymphatic System: leukocytosis. Ingestion: constipation, cholangitis, flatulence, and vomiting. The organism as a whole: ascites, fatigue, bleeding, bacterial, fungal and . viral infections, malaiseCardiovascular: vasodilation (decreased blood pressure, redness of the skin). Central and peripheral nervous system: depression, dizziness, insomnia. liver and biliary ways: cholestatic jaundice. skin:increased sweating. Special senses: amblyopia, taste disturbances. metabolic and nutritional: diabetes mellitus, hyponatremia, hypoproteinemia, weight loss.


Other adverse events

The following are significant adverse effects, which primobolan depot were not mentioned above, since did not meet the inclusion criteria (less than 2%). the blood system and lymphatic system: aplastic anemia, myelosuppression, eosinophilia. Ingestion: gastrointestinal bleeding, eructation, fecal incontinence, ulcerative stomatitis, pancreatitis, glossitis. Infections: episodes of infections caused by depression bone marrow and immune system (local and systemic infection and sepsis). bleeding: potentially life-threatening bleeding in thrombocytopenia. body as a whole: cachexia, dehydration, weakness, thrombosis, injection site abscess at the injection site, swelling at the injection site pain at the injection site, haemorrhage at the injection site, malaise, photosensitivity reaction.

Central and peripheral nervous system:agitation, convulsions, hallucinations, psychosis, thought disorder, “nightmarish” dream, ataxia, coma, dry mouth, euphoria, nervousness, somnolence. Skin and appendages: dermatitis, acne, alopecia, herpes simplex, urticaria. sensory organs: retinal detachment, visual impairment, blindness, hearing loss, pain in the eyeball, glaucoma, floater. Laboratory indicators: increase in creatine kinase activity and lactate dehydrogenase in blood, hypoglycemia. urinary tract: urinary frequency. Cardiovascular system: arrhythmia primobolan depot, deep vein thrombophlebitis, migraine, phlebitis. Musculoskeletal system: myasthenic syndrome.

The experience of post-marketing use of the drug
adverse events, according to the spontaneous messages in the application of ganciclovir in HIV-infected patients and other immunocompromised primobolan depot patients (eg, post-transplant), for which we can not exclude a causal relationship with the drug: anaphylaxis, reduced fertility in men.
In otherwise undesirable phenomena described during post-registration application of the drug are similar to those observed in clinical studies.